Press Resease

Point Of Care Testing Market - Global Industry Analysis

Point Of Care Testing Market By Product, (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Fecal Occult Testing Products, Hematology Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Drugs-of-abuse Testing Products, Cholesterol Testing Products, Other POC Products) By Platform, (Lateral Flow Assays, Immunoassays, Microfluidics 1, Molecular Diagnostics, Dipsticks) By Mode of Purchase, (OTC Testing Products, Prescription-based Testing Products) By End Users (Outpatient & Ambulatory Care Facilities, Hospitals & Critical Care Centers, Home Care Settings 5, Other End Users) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2021-2028

Published Date: 07-Sep-2021 Category: Medical Device Report Format : PDF Pages: 168 Report Code: ZMR-6004 Status : Published

Global Point Of Care Testing market accounted for USD 31.17 Billion in 2020 and is expected to reach USD 78.85 Billion by 2028, growing at a CAGR of 12.3% from 2021 to 2028.

Description

Market Overview

In terms of revenue, the global Point Of Care Testing market accounted for USD 31.17 Billion in 2020 and is expected to reach USD 78.85 Billion by 2028, growing at a CAGR of 12.3% from 2021 to 2028.

Point of care (POC) testing devices are mainly used for diagnosis of disease for early detection and monitoring along with its effective treatment and management. During last decades there is a significant growth in the pervasiveness of chronic diseases which has led to upsurge the patient inflow. Point of care test is beneficial in providing the instantaneous results to the patient. However, although there are good opportunities for the growth of the market. To introduce the test and devices into the market the product has to meet the strict government regulations for devices or test. This stringent government regulations and poor reimbursement policies may hinder the growth of the market during the forecasted period. The decentralization of healthcare is one of the major trends observed in patient care now a days which is anticipated to offer new growth opportunities to the overall point of care (POC) testing industry.

Global Point Of Care Testing Market

COVID-19 Impact Analysis

COVID-19 is a global public emergency which have led us to serious consequences for all the sectors as it have reduced the growth to a significant level. World is still suffering through COVID-19 outbreak posing social, health, and economic emergency. It’s been a year now since the outbreak of COVID-19 hindering the various markets causing the significant loss in the revenue. However, Healthcare sector, research & development activities can be seen to get on track with new inflow of investments.

Point of care (POC) testing devices and research and development activities are some of the severely affected areas of point of care molecular diagnostic market due to COVID-19 outbreak. However, the outbreak of COVID-19 has accelerated the global demand for diagnostic kits to rapidly detect the diseases. Thus, many players are emphazing on increasing the supply of tests worldwide.

Growth Factors

The global Point of care (POC) testing Market is majorly driven by increasing dominance of the infectious diseases, hematological diseases, cancer, and others. Owing to the increase in chronic diseases and the patients suffering from it, healthcare awareness among the people is increasing tremendously which can be the factor responsible for the growth of the Point Of Care Testing Market. Increasing government support and increasing awareness among the people have fueled the growth of the Point of care (POC) testing market. Also, Factors such as the rising number of clinics adopting Point of care (POC) testing for the rapid detection of infectious diseases in the near future are expected to drive market growth during the forecast period.

However, multi-layered regulations set by the FDA and laboratory regulations under CLIA can restrain the growth of Point of care (POC) testing Market.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Product Segment Analysis Preview:

Based on product, the Point Of Care Testing Market is segmented into, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Fecal Occult Testing Products, Hematology Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Drugs-of-abuse Testing Products, Cholesterol Testing Products, Other POC Products.

Product Segment is anticipated to help the largest share owing to acceptance of new technologies among researchers and academia technological advancements, large base of population suffering from chronic and acute diseases.

By End Users Segment Analysis Preview:

Based on End Users, the Point Of Care Testing Market is segmented into, Outpatient & Ambulatory Care Facilities, Hospitals & Critical Care Centers, Home Care Settings 5, Other End Users.

Owing to increasing in number of end users such as hospitals and clinics, Outpatient & Ambulatory Care Facilities and other end users, and adoption of new technologies, the Point Of Care Testing Market are expected to drive market growth during the forecast period.

Global Point Of Care Testing Market Share

Regional Analysis Preview

North America holds the largest share in the global point of care molecular diagnostic market owing to the huge patient population well developed economy and high healthcare expenditure. Also, north America include the major key players and Supportive government scenarios and higher people awareness of self-testing and home care products and significant adoption of novel technologies can be the responsible factors to increase the market growth.

Asia Pacific is anticipated to be the fastest growing market with the CAGR of XX%. The presence of huge opportunity for the development of the market and huge population base in this region, are some of the major castors responsible for the growth of point of care testing market in Asia pacific region.

Global Point Of Care Testing Market Regional Analysis

Key Market Players & Competitive Landscape

Some of key players in Point Of Care Testing Market are,

  1. Roche Diagnostics
  2. Abbott Laboratories
  3. Siemens Healthineers
  4. Becton, Dickinson and Company
  5. Johnson & Johnson
  6. Danaher Corporation
  7. Chembio Diagnostics
  8. Quidel Corporation
  9. EKF Diagnostics
  10. Trinity Biotech

The Point Of Care Testing Market is segmented as follows:

By Product

  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Infectious Disease Testing Products
  • Coagulation Monitoring Products
  • Pregnancy & Fertility Testing Products
  • Fecal Occult Testing Products
  • Hematology Testing Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Drugs-of-abuse Testing Products
  • Cholesterol Testing Products
  • Other POC Products

By Platform

  • Lateral Flow Assays
  • Immunoassays
  • Microfluidics 1
  • Molecular Diagnostics
  • Dipsticks

By Mode of Purchase

  • OTC Testing Products
  • Prescription-based Testing Products

By End Users

  • Outpatient & Ambulatory Care Facilities
  • Hospitals & Critical Care Centers
  • Home Care Settings 5
  • Other End Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • CHAPTER NO. 1 INTRODUCTION
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • CHAPTER NO. 2 EXECUTIVE SUMMARY
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By Platform
        • 2.1.1.3. Market Attractiveness Analysis, By Mode of Purchase
        • 2.1.1.4. Market Attractiveness Analysis, By End Users
        • 2.1.1.5. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Point Of Care Testing Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • CHAPTER NO. 3 COVID 19 IMPACT ANALYSIS
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • CHAPTER NO. 4 POINT OF CARE TESTING MARKET – BY PRODUCT SEGMENT ANALYSIS
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Glucose Monitoring Products
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Cardiometabulic Monitoring Products
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Infectious Disease Testing Products
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Coagulation Monitoring Products
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Pregnancy & Fertility Testing Products
      • 4.6.1. Market Size and Forecast, By Region (USD Million)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Fecal Occult Testing Products
      • 4.7.1. Market Size and Forecast, By Region (USD Million)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.8. Hematulogy Testing Products
      • 4.8.1. Market Size and Forecast, By Region (USD Million)
      • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.9. Tumor/Cancer Marker Testing Products
      • 4.9.1. Market Size and Forecast, By Region (USD Million)
      • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.10. Urinalysis Testing Products
      • 4.10.1. Market Size and Forecast, By Region (USD Million)
      • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.11. Drugs-of-abuse Testing Products
      • 4.11.1. Market Size and Forecast, By Region (USD Million)
      • 4.11.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.11.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.12. Chulesterul Testing Products
      • 4.12.1. Market Size and Forecast, By Region (USD Million)
      • 4.12.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.12.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.13. Other POC Products
      • 4.13.1. Market Size and Forecast, By Region (USD Million)
      • 4.13.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.13.3. Key Market Trends, Growth Factors, & Opportunities
  • CHAPTER NO. 5 POINT OF CARE TESTING MARKET – BY PLATFORM SEGMENT ANALYSIS
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Platform, 2020 & 2028
    • 5.2. Lateral Flow Assays
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Immunoassays
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Microfluidics 1
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Mulecular Diagnostics
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Dipsticks
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
  • CHAPTER NO. 6 POINT OF CARE TESTING MARKET – BY MODE OF PURCHASE SEGMENT ANALYSIS
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Mode of Purchase, 2020 & 2028
    • 6.2. OTC Testing Products
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Prescription-based Testing Products
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • CHAPTER NO. 7 POINT OF CARE TESTING MARKET – BY END USERS SEGMENT ANALYSIS
    • 7.1. Overview
      • 7.1.1. Market Revenue Share, By End Users, 2020 & 2028
    • 7.2. Outpatient & Ambulatory Care Facilities
      • 7.2.1. Market Size and Forecast, By Region (USD Million)
      • 7.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.3. Hospitals & Critical Care Centers
      • 7.3.1. Market Size and Forecast, By Region (USD Million)
      • 7.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.4. Home Care Settings 5
      • 7.4.1. Market Size and Forecast, By Region (USD Million)
      • 7.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 7.5. Other End Users
      • 7.5.1. Market Size and Forecast, By Region (USD Million)
      • 7.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 7.5.3. Key Market Trends, Growth Factors, & Opportunities
  • CHAPTER NO. 8 POINT OF CARE TESTING MARKET – REGIONAL ANALYSIS
    • 8.1. Overview
      • 8.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 8.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 8.2. North America
      • 8.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 8.2.3. North America Market Revenue, By Platform, 2016 – 2028
      • 8.2.4. North America Market Revenue, By Mode of Purchase, 2016 – 2028
      • 8.2.5. North America Market Revenue, By End Users, 2016 – 2028
      • 8.2.6. U.S.
        • 8.2.6.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 8.2.6.2. U.S. Market Revenue, By Platform, 2016 – 2028
        • 8.2.6.3. U.S. Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.2.6.4. U.S. Market Revenue, By End Users, 2016 – 2028
      • 8.2.7. Canada
        • 8.2.7.1. Canada Market Revenue, By Product, 2016 – 2028
        • 8.2.7.2. Canada Market Revenue, By Platform, 2016 – 2028
        • 8.2.7.3. Canada Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.2.7.4. Canada Market Revenue, By End Users, 2016 – 2028
      • 8.2.8. Mexico
        • 8.2.8.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 8.2.8.2. Mexico Market Revenue, By Platform, 2016 – 2028
        • 8.2.8.3. Mexico Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.2.8.4. Mexico Market Revenue, By End Users, 2016 – 2028
    • 8.3. Europe
      • 8.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 8.3.3. Europe Market Revenue, By Platform, 2016 – 2028
      • 8.3.4. Europe Market Revenue, By Mode of Purchase, 2016 – 2028
      • 8.3.5. Europe Market Revenue, By End Users, 2016 – 2028
      • 8.3.6. Germany
        • 8.3.6.1. Germany Market Revenue, By Product, 2016 – 2028
        • 8.3.6.2. Germany Market Revenue, By Platform, 2016 – 2028
        • 8.3.6.3. Germany Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.3.6.4. Germany Market Revenue, By End Users, 2016 – 2028
      • 8.3.7. France
        • 8.3.7.1. France Market Revenue, By Product, 2016 – 2028
        • 8.3.7.2. France Market Revenue, By Platform, 2016 – 2028
        • 8.3.7.3. France Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.3.7.4. France Market Revenue, By End Users, 2016 – 2028
      • 8.3.8. U.K.
        • 8.3.8.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 8.3.8.2. U.K. Market Revenue, By Platform, 2016 – 2028
        • 8.3.8.3. U.K. Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.3.8.4. U.K. Market Revenue, By End Users, 2016 – 2028
      • 8.3.9. Italy
        • 8.3.9.1. Italy Market Revenue, By Product, 2016 – 2028
        • 8.3.9.2. Italy Market Revenue, By Platform, 2016 – 2028
        • 8.3.9.3. Italy Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.3.9.4. Italy Market Revenue, By End Users, 2016 – 2028
      • 8.3.10. Spain
        • 8.3.10.1. Spain Market Revenue, By Product, 2016 – 2028
        • 8.3.10.2. Spain Market Revenue, By Platform, 2016 – 2028
        • 8.3.10.3. Spain Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.3.10.4. Spain Market Revenue, By End Users, 2016 – 2028
      • 8.3.11. Rest of Europe
        • 8.3.11.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 8.3.11.2. Rest of Europe Market Revenue, By Platform, 2016 – 2028
        • 8.3.11.3. Rest of Europe Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.3.11.4. Rest of Europe Market Revenue, By End Users, 2016 – 2028
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 8.4.3. Asia Pacific Market Revenue, By Platform, 2016 – 2028
      • 8.4.4. Asia Pacific Market Revenue, By Mode of Purchase, 2016 – 2028
      • 8.4.5. Asia Pacific Market Revenue, By End Users, 2016 – 2028
      • 8.4.6. China
        • 8.4.6.1. China Market Revenue, By Product, 2016 – 2028
        • 8.4.6.2. China Market Revenue, By Platform, 2016 – 2028
        • 8.4.6.3. China Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.4.6.4. China Market Revenue, By End Users, 2016 – 2028
      • 8.4.7. Japan
        • 8.4.7.1. Japan Market Revenue, By Product, 2016 – 2028
        • 8.4.7.2. Japan Market Revenue, By Platform, 2016 – 2028
        • 8.4.7.3. Japan Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.4.7.4. Japan Market Revenue, By End Users, 2016 – 2028
      • 8.4.8. India
        • 8.4.8.1. India Market Revenue, By Product, 2016 – 2028
        • 8.4.8.2. India Market Revenue, By Platform, 2016 – 2028
        • 8.4.8.3. India Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.4.8.4. India Market Revenue, By End Users, 2016 – 2028
      • 8.4.9. South Korea
        • 8.4.9.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 8.4.9.2. South Korea Market Revenue, By Platform, 2016 – 2028
        • 8.4.9.3. South Korea Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.4.9.4. South Korea Market Revenue, By End Users, 2016 – 2028
      • 8.4.10. South-East Asia
        • 8.4.10.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 8.4.10.2. South-East Asia Market Revenue, By Platform, 2016 – 2028
        • 8.4.10.3. South-East Asia Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.4.10.4. South-East Asia Market Revenue, By End Users, 2016 – 2028
      • 8.4.11. Rest of Asia Pacific
        • 8.4.11.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 8.4.11.2. Rest of Asia Pacific Market Revenue, By Platform, 2016 – 2028
        • 8.4.11.3. Rest of Asia Pacific Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.4.11.4. Rest of Asia Pacific Market Revenue, By End Users, 2016 – 2028
    • 8.5. Latin America
      • 8.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 8.5.3. Latin America Market Revenue, By Platform, 2016 – 2028
      • 8.5.4. Latin America Market Revenue, By Mode of Purchase, 2016 – 2028
      • 8.5.5. Latin America Market Revenue, By End Users, 2016 – 2028
      • 8.5.6. Brazil
        • 8.5.6.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 8.5.6.2. Brazil Market Revenue, By Platform, 2016 – 2028
        • 8.5.6.3. Brazil Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.5.6.4. Brazil Market Revenue, By End Users, 2016 – 2028
      • 8.5.7. Argentina
        • 8.5.7.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 8.5.7.2. Argentina Market Revenue, By Platform, 2016 – 2028
        • 8.5.7.3. Argentina Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.5.7.4. Argentina Market Revenue, By End Users, 2016 – 2028
      • 8.5.8. Rest of Latin America
        • 8.5.8.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 8.5.8.2. Rest of Latin America Market Revenue, By Platform, 2016 – 2028
        • 8.5.8.3. Rest of Latin America Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.5.8.4. Rest of Latin America Market Revenue, By End Users, 2016 – 2028
    • 8.6. The Middle-East and Africa
      • 8.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 8.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 8.6.3. The Middle-East and Africa Market Revenue, By Platform, 2016 – 2028
      • 8.6.4. The Middle-East and Africa Market Revenue, By Mode of Purchase, 2016 – 2028
      • 8.6.5. The Middle-East and Africa Market Revenue, By End Users, 2016 – 2028
      • 8.6.6. GCC Countries
        • 8.6.6.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 8.6.6.2. GCC Countries Market Revenue, By Platform, 2016 – 2028
        • 8.6.6.3. GCC Countries Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.6.6.4. GCC Countries Market Revenue, By End Users, 2016 – 2028
      • 8.6.7. South Africa
        • 8.6.7.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 8.6.7.2. South Africa Market Revenue, By Platform, 2016 – 2028
        • 8.6.7.3. South Africa Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.6.7.4. South Africa Market Revenue, By End Users, 2016 – 2028
      • 8.6.8. Rest of Middle-East Africa
        • 8.6.8.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 8.6.8.2. Rest of Middle-East Africa Market Revenue, By Platform, 2016 – 2028
        • 8.6.8.3. Rest of Middle-East Africa Market Revenue, By Mode of Purchase, 2016 – 2028
        • 8.6.8.4. Rest of Middle-East Africa Market Revenue, By End Users, 2016 – 2028
  • CHAPTER NO. 9 POINT OF CARE TESTING MARKET – INDUSTRY ANALYSIS
    • 9.1. Introduction
    • 9.2. Market Drivers
      • 9.2.1. Driving Factor 1 Analysis
      • 9.2.2. Driving Factor 2 Analysis
    • 9.3. Market Restraints
      • 9.3.1. Restraining Factor Analysis
    • 9.4. Market Opportunities
      • 9.4.1. Market Opportunity Analysis
    • 9.5. Porter’s Five Forces Analysis
    • 9.6. PEST Analysis
    • 9.7. Regulatory Landscape
    • 9.8. Technology Landscape
    • 9.9. Regional Market Trends
      • 9.9.1. North America
      • 9.9.2. Europe
      • 9.9.3. Asia Pacific
      • 9.9.4. Latin America
      • 9.9.5. The Middle-East and Africa
    • 9.10. Pricing Analysis
    • 9.11. Value Chain Analysis
    • 9.12. Downstream Buyers
    • 9.13. Distributors/Traders List
  • CHAPTER NO. 10 COMPETITIVE LANDSCAPE
    • 10.1. Company Market Share Analysis – 2019
      • 10.1.1. Global Point Of Care Testing Market: Company Market Share, 2019
      • 10.1.2. Global Point Of Care Testing Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 10.1.3. Global Point Of Care Testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 10.1.4. Global Point Of Care Testing Market: Radar Determinant Chart, 2019
    • 10.2. Strategic Developments
      • 10.2.1. Acquisitions & Mergers
      • 10.2.2. New Product Launch
      • 10.2.3. Regional Expansion
    • 10.3. Company Strategic Developments – Heat Map Analysis
  • CHAPTER NO. 11 COMPANY PROFILES
    • 11.1. Roche Diagnostics
      • 11.1.1. Company Overview
      • 11.1.2. Key Executives
      • 11.1.3. Product Portfolio
      • 11.1.4. Financial Overview
      • 11.1.5. Operating Business Segments
      • 11.1.6. Business Performance
      • 11.1.7. Recent Developments
    • 11.2. Abbott Laboratories
    • 11.3. Siemens Healthineers
    • 11.4. Becton, Dickinson and Company
    • 11.5. Johnson & Johnson
    • 11.6. Danaher Corporation
    • 11.7. Chembio Diagnostics
    • 11.8. Quidel Corporation
    • 11.9. EKF Diagnostics
    • 11.10. Trinity Biotech
  • CHAPTER NO. 12 MARKETING STRATEGY ANALYSIS
    • 12.1. Marketing Channel
    • 12.2. Direct Marketing
    • 12.3. Indirect Marketing
    • 12.4. Marketing Channel Development Trends
    • 12.5. Economic/Pulitical Environmental Change
  • CHAPTER NO. 13 RESEARCH METHODulOGY
    • 13.1. Research Methodology
    • 13.2. Phase I - Secondary Research
    • 13.3. Phase II - Data Modeling
      • 13.3.1. Company Share Analysis Model
      • 13.3.2. Revenue Based Modeling
    • 13.4. Phase III - Primary Research
    • 13.5. Research Limitations
      • 13.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By Platform
FIG NO. 3. Market Attractiveness Analysis, By Mode of Purchase
FIG NO. 4. Market Attractiveness Analysis, By End Users
FIG NO. 5. Market Attractiveness Analysis, By Region
FIG NO. 6. Global Point Of Care Testing Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 7. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 8. Market Revenue Share, By Product, 2020 & 2028
FIG NO. 9. Global Point Of Care Testing Market for Glucose Monitoring Products, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Point Of Care Testing Market for Glucose Monitoring Products, By Country, 2020 & 2028
FIG NO. 11. Global Point Of Care Testing Market for Cardiometabolic Monitoring Products, Revenue (USD Million) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Point Of Care Testing Market for Cardiometabolic Monitoring Products, By Country, 2020 & 2028
FIG NO. 13. Global Point Of Care Testing Market for Infectious Disease Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Point Of Care Testing Market for Infectious Disease Testing Products, By Country, 2020 & 2028
FIG NO. 15. Global Point Of Care Testing Market for Coagulation Monitoring Products, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Point Of Care Testing Market for Coagulation Monitoring Products, By Country, 2020 & 2028
FIG NO. 17. Global Point Of Care Testing Market for Pregnancy & Fertility Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Point Of Care Testing Market for Pregnancy & Fertility Testing Products, By Country, 2020 & 2028
FIG NO. 19. Global Point Of Care Testing Market for Fecal Occult Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Point Of Care Testing Market for Fecal Occult Testing Products, By Country, 2020 & 2028
FIG NO. 21. Global Point Of Care Testing Market for Hematology Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Point Of Care Testing Market for Hematology Testing Products, By Country, 2020 & 2028
FIG NO. 23. Global Point Of Care Testing Market for Tumor/Cancer Marker Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Point Of Care Testing Market for Tumor/Cancer Marker Testing Products, By Country, 2020 & 2028
FIG NO. 25. Global Point Of Care Testing Market for Urinalysis Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Point Of Care Testing Market for Urinalysis Testing Products, By Country, 2020 & 2028
FIG NO. 27. Global Point Of Care Testing Market for Drugs-of-abuse Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Point Of Care Testing Market for Drugs-of-abuse Testing Products, By Country, 2020 & 2028
FIG NO. 29. Global Point Of Care Testing Market for Cholesterol Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of Point Of Care Testing Market for Cholesterol Testing Products, By Country, 2020 & 2028
FIG NO. 31. Global Point Of Care Testing Market for Other POC Products, Revenue (USD Million) 2016 – 2028
FIG NO. 32. Comparative Revenue Analysis of Point Of Care Testing Market for Other POC Products, By Country, 2020 & 2028
FIG NO. 33. Market Revenue Share, By Platform, 2020 & 2028
FIG NO. 34. Global Point Of Care Testing Market for Lateral Flow Assays, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Point Of Care Testing Market for Lateral Flow Assays, By Country, 2020 & 2028
FIG NO. 36. Global Point Of Care Testing Market for Immunoassays, Revenue (USD Million) 2016 – 2028
FIG NO. 37. Comparative Revenue Analysis of Point Of Care Testing Market for Immunoassays, By Country, 2020 & 2028
FIG NO. 38. Global Point Of Care Testing Market for Microfluidics 1, Revenue (USD Million) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Point Of Care Testing Market for Microfluidics 1, By Country, 2020 & 2028
FIG NO. 40. Global Point Of Care Testing Market for Molecular Diagnostics, Revenue (USD Million) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Point Of Care Testing Market for Molecular Diagnostics, By Country, 2020 & 2028
FIG NO. 42. Global Point Of Care Testing Market for Dipsticks, Revenue (USD Million) 2016 – 2028
FIG NO. 43. Comparative Revenue Analysis of Point Of Care Testing Market for Dipsticks, By Country, 2020 & 2028
FIG NO. 44. Market Revenue Share, By Mode of Purchase, 2020 & 2028
FIG NO. 45. Global Point Of Care Testing Market for OTC Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 46. Comparative Revenue Analysis of Point Of Care Testing Market for OTC Testing Products, By Country, 2020 & 2028
FIG NO. 47. Global Point Of Care Testing Market for Prescription-based Testing Products, Revenue (USD Million) 2016 – 2028
FIG NO. 48. Comparative Revenue Analysis of Point Of Care Testing Market for Prescription-based Testing Products, By Country, 2020 & 2028
FIG NO. 49. Market Revenue Share, By End Users, 2020 & 2028
FIG NO. 50. Global Point Of Care Testing Market for Outpatient & Ambulatory Care Facilities, Revenue (USD Million) 2016 – 2028
FIG NO. 51. Comparative Revenue Analysis of Point Of Care Testing Market for Outpatient & Ambulatory Care Facilities, By Country, 2020 & 2028
FIG NO. 52. Global Point Of Care Testing Market for Hospitals & Critical Care Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 53. Comparative Revenue Analysis of Point Of Care Testing Market for Hospitals & Critical Care Centers, By Country, 2020 & 2028
FIG NO. 54. Global Point Of Care Testing Market for Home Care Settings 5, Revenue (USD Million) 2016 – 2028
FIG NO. 55. Comparative Revenue Analysis of Point Of Care Testing Market for Home Care Settings 5, By Country, 2020 & 2028
FIG NO. 56. Global Point Of Care Testing Market for Other End Users, Revenue (USD Million) 2016 – 2028
FIG NO. 57. Comparative Revenue Analysis of Point Of Care Testing Market for Other End Users, By Country, 2020 & 2028
FIG NO. 58. Global Point Of Care Testing Market Revenue Share, By Region, 2020 & 2028
FIG NO. 59. North America Point Of Care Testing Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 60. Porter’s Five Forces Analysis for Global Point Of Care Testing Market
FIG NO. 61. PEST Analysis for Global Point Of Care Testing Market
FIG NO. 62. Pricing Analysis for Global Point Of Care Testing Market
FIG NO. 63. Value Chain Analysis for Global Point Of Care Testing Market
FIG NO. 64. Company Share Analysis, 2019
FIG NO. 65. Radar Determinant Chart, 2019
FIG NO. 66. Company Strategic Developments – Heat Map Analysis
FIG NO. 67. Roche Diagnostics Business Segment Revenue Share, 2020 (%)
FIG NO. 68. Roche Diagnostics Geographical Segment Revenue Share, 2020 (%)
FIG NO. 69. Market Channels
FIG NO. 70. Marketing Channel Development Trend
FIG NO. 71. Growth in World Gross Product, 2008-2018
FIG NO. 72. Research Methodology – Detailed View
FIG NO. 73. Research Methodology


List of Tables 

TABLE NO. 1 Global Point Of Care Testing Market: Snapshot
TABLE NO. 2 Quarterly Point Of Care Testing Market Revenue by Region, 2020
TABLE NO. 3 Quarterly Point Of Care Testing Market Revenue Forecast by Region, 2021
TABLE NO. 4 Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5 Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6 Global Point Of Care Testing Market for Glucose Monitoring Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7 Global Point Of Care Testing Market for Cardiometabolic Monitoring Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8 Global Point Of Care Testing Market for Infectious Disease Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9 Global Point Of Care Testing Market for Coagulation Monitoring Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10 Global Point Of Care Testing Market for Pregnancy & Fertility Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11 Global Point Of Care Testing Market for Fecal Occult Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12 Global Point Of Care Testing Market for Hematology Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13 Global Point Of Care Testing Market for Tumor/Cancer Marker Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14 Global Point Of Care Testing Market for Urinalysis Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15 Global Point Of Care Testing Market for Drugs-of-abuse Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16 Global Point Of Care Testing Market for Cholesterol Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17 Global Point Of Care Testing Market for Other POC Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18 Global Point Of Care Testing Market for Lateral Flow Assays, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19 Global Point Of Care Testing Market for Immunoassays, by Region, 2016 – 2028 (USD Million)
TABLE NO. 20 Global Point Of Care Testing Market for Microfluidics 1, by Region, 2016 – 2028 (USD Million)
TABLE NO. 21 Global Point Of Care Testing Market for Molecular Diagnostics, by Region, 2016 – 2028 (USD Million)
TABLE NO. 22 Global Point Of Care Testing Market for Dipsticks, by Region, 2016 – 2028 (USD Million)
TABLE NO. 23 Global Point Of Care Testing Market for OTC Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 24 Global Point Of Care Testing Market for Prescription-based Testing Products, by Region, 2016 – 2028 (USD Million)
TABLE NO. 25 Global Point Of Care Testing Market for Outpatient & Ambulatory Care Facilities, by Region, 2016 – 2028 (USD Million)
TABLE NO. 26 Global Point Of Care Testing Market for Hospitals & Critical Care Centers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 27 Global Point Of Care Testing Market for Home Care Settings 5, by Region, 2016 – 2028 (USD Million)
TABLE NO. 28 Global Point Of Care Testing Market for Other End Users, by Region, 2016 – 2028 (USD Million)
TABLE NO. 29 Global Point Of Care Testing Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 30 North America Point Of Care Testing Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 31 North America Point Of Care Testing Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 32 North America Point Of Care Testing Market Revenue, By Platform, 2016 – 2028 (USD Million)
TABLE NO. 33 North America Point Of Care Testing Market Revenue, By Mode of Purchase, 2016 – 2028 (USD Million)
TABLE NO. 34 North America Point Of Care Testing Market Revenue, By End Users, 2016 – 2028 (USD Million)
TABLE NO. 35 U.S. Point Of Care Testing Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 36 U.S. Point Of Care Testing Market Revenue, By Platform, 2016 – 2028 (USD Million)
TABLE NO. 37 U.S. Point Of Care Testing Market Revenue, By Mode of Purchase, 2016 – 2028 (USD Million)
TABLE NO. 38 U.S. Point Of Care Testing Market Revenue, By End Users, 2016 – 2028 (USD Million)
TABLE NO. 39 Canada Point Of Care Testing Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 40 Canada Point Of Care Testing Market Revenue, By Platform, 2016 – 2028 (USD Million)
TABLE NO. 41 Canada Point Of Care Testing Market Revenue, By Mode of Purchase, 2016 – 2028 (USD Million)
TABLE NO. 42 Canada Point Of Care Testing Market Revenue, By End Users, 2016 – 2028 (USD Million)
TABLE NO. 43 Mexico Point Of Care Testing Market Revenue, By Product, 2016 – 2028 (USD Million)
TABLE NO. 44 Mexico Point Of Care Testing Market Revenue, By Platform, 2016 – 2028 (USD Million)
TABLE NO. 45 Mexico Point Of Care Testing Market Revenue, By Mode of Purchase, 2016 – 2028 (USD Million)
TABLE NO. 46 Mexico Point Of Care Testing Market Revenue, By End Users, 2016 – 2028 (USD Million)
TABLE NO. 47 Drivers for the Point Of Care Testing Market: Impact Analysis
TABLE NO. 48 Restraints for the Point Of Care Testing Market: Impact Analysis
TABLE NO. 49 Major Buyers of Point Of Care Testing
TABLE NO. 50 Distributors/Traders List of Point Of Care Testing
TABLE NO. 51 Global Point Of Care Testing Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 52 Global Point Of Care Testing Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Point Of Care Testing Market was valued at USD 31.17 Billion in 2020.

The global Point Of Care Testing Market is expected to reach USD 78.85 Billion by 2028, growing at a CAGR of 12.3% between 2021 to 2028.

The global Point of care (POC) testing Market is majorly driven by increasing dominance of the infectious diseases, hematological diseases, cancer, and others. Owing to the increase in chronic diseases and the patients suffering from it, healthcare awareness among the people is increasing tremendously which can be the factor responsible for the growth of the Point Of Care Testing Market.

North America held a substantial share of the Point Of Care Testing Market in 2020.

Some of the major companies operating in the Point Of Care Testing Market are Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation, Chembio Diagnostics, Quidel Corporation, EKF Diagnostics, Trinity Biotech, AccuBioTech, Nova Biomedical, PTS Diagnostics, Instrumentation Laboratory Company, and Sekisui Diagnostics.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed